EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options

Li Pang, Lei-Bo Xu, Wen-Rui Wu

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.05.041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Li Pang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplantation Center & Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Gua…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Patient Selection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation (LT) is an ideal therapeutic option for selected patients with hepatocellular carcinoma (HCC). The selection criteria of HCC for LT have evolved in recent decades. Downstaging therapy is a promising strategy for patients with tumor burden beyond transplant criteria to increase the chance of receiving LT and improve posttransplant survival. Downstaging therapy is also a selection tool that refines the conventional selection criteria based on tumor morphology. Recently, the success of systemic treatment, including immune checkpoint inhibitors, antiangiogenic tyrosine kinase inhibitors, and VEGF inhibitors, in advanced HCC has prompted the discussion regarding the role of systemic therapies for HCC downstaging before transplantation. In this review, we aimed to summarize the current advances in selection criteria and therapeutic options of downstaging therapy for HCC before LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationPatient SelectionHumansNeoplasm Staging

Autor:innen und Institutionen

  • Liver Transplantation Center & Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Ge…

Zitieren

APA

Pang, L., Xu, L. B., & Wu, W. R. (2024). Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.041

Vancouver

Pang L, Xu LB, Wu WR. Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.041

BibTeX
@article{Pang2024,
  author = {Pang, Li and Xu, Lei-Bo and Wu, Wen-Rui},
  title = {Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.05.041}
}
Kostenlos starten →